An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease
- PMID: 7105424
- DOI: 10.1016/0009-8981(82)90145-0
An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease
Abstract
By means of a computerized calculation program, a simplified estimate of the ion-activity product of calcium oxalate was derived (AP(CaOx)-index), based on the 24-h urinary excretion of calcium (Ca), oxalate (Ox), magnesium (Mg), citrate (Cit) and the urine volume (V): (formula: see text) With urinary electrolyte values within the normal range, there was a good correlation between the AP(CaOx)-index and the more laboriously obtained ion-activity product (r = 0.997). To express the biochemical risk of CaOx stone formation a CaOx-risk index was designed, which also includes the inhibition of calcium oxalate crystal growth (I) and with all variables related to urinary creatinine (Cr): (formula: see text) The mean CaOx-risk index (+/-SEM) in urine from 100 normal men and 156 male stone formers were 648 +/- 27 and 1019 +/- 38 respectively (p less than 0.001). A risk index without inhibition index, had the corresponding values 366 +/- 14 and 527 +/- 17 (p less than 0.001).
Similar articles
-
The composition of four-hour urine samples from patients with calcium oxalate stone disease.Br J Urol. 1987 Oct;60(4):301-6. doi: 10.1111/j.1464-410x.1987.tb04972.x. Br J Urol. 1987. PMID: 3690199
-
Aspects on estimation of the risk of calcium oxalate crystallization in urine.Urol Int. 1991;47(4):255-9. doi: 10.1159/000282232. Urol Int. 1991. PMID: 1781112
-
How are urine composition and stone disease affected by therapeutic measures at an outpatient stone clinic?Eur Urol. 1990;17(3):206-12. doi: 10.1159/000464039. Eur Urol. 1990. PMID: 2351189
-
Effects of citrate on the different phases of calcium oxalate crystallization.Scanning Microsc. 1993 Mar;7(1):381-9; discussion 389-90. Scanning Microsc. 1993. PMID: 8316807 Review.
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
Cited by
-
Simplified estimates of ion-activity products of calcium oxalate and calcium phosphate in mouse urine.Urol Res. 2012 Aug;40(4):285-91. doi: 10.1007/s00240-011-0443-1. Epub 2011 Dec 27. Urol Res. 2012. PMID: 22200737
-
Calcium oxalate saturation in dialysis patients with and without primary hyperoxaluria.Urol Res. 2006 Feb;34(1):12-6. doi: 10.1007/s00240-005-0004-6. Epub 2006 Jan 24. Urol Res. 2006. PMID: 16432691
-
Crystal growth of calcium oxalate in urine of stone-formers and normal controls.Urol Res. 1991;19(3):159-64. doi: 10.1007/BF00303742. Urol Res. 1991. PMID: 1887523
-
Relationship of endoscopic lesions of the renal papilla with type of renal stone and 24 h urine analysis.BMC Urol. 2020 Apr 25;20(1):46. doi: 10.1186/s12894-020-00615-4. BMC Urol. 2020. PMID: 32334600 Free PMC article.
-
Folium pyrrosiae ingestion has no effect on the thermodynamic or kinetic urinary risk factors for calcium oxalate urolithiasis in healthy subjects: a poor prognosis for alternative treatment in this type of stone former.Urolithiasis. 2015 Feb;43(1):21-7. doi: 10.1007/s00240-014-0722-8. Epub 2014 Sep 20. Urolithiasis. 2015. PMID: 25238730
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources